173 related articles for article (PubMed ID: 21940621)
1. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
Pappatà S; Santangelo G; Aarsland D; Vicidomini C; Longo K; Bronnick K; Amboni M; Erro R; Vitale C; Caprio MG; Pellecchia MT; Brunetti A; De Michele G; Salvatore M; Barone P
Neurology; 2011 Oct; 77(14):1357-62. PubMed ID: 21940621
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
[TBL] [Abstract][Full Text] [Related]
3. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
[TBL] [Abstract][Full Text] [Related]
4. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
[TBL] [Abstract][Full Text] [Related]
5. Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease.
De Rosa A; Peluso S; De Lucia N; Russo P; Annarumma I; Esposito M; Manganelli F; Brunetti A; De Michele G; Pappatà S
Parkinsonism Relat Disord; 2018 Feb; 47():80-83. PubMed ID: 29249679
[TBL] [Abstract][Full Text] [Related]
6. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
Drzezga A; Lautenschlager N; Siebner H; Riemenschneider M; Willoch F; Minoshima S; Schwaiger M; Kurz A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1104-13. PubMed ID: 12764551
[TBL] [Abstract][Full Text] [Related]
7. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
[TBL] [Abstract][Full Text] [Related]
8. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
Liepelt I; Reimold M; Maetzler W; Godau J; Reischl G; Gaenslen A; Herbst H; Berg D
Mov Disord; 2009 Jul; 24(10):1504-11. PubMed ID: 19489069
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
[TBL] [Abstract][Full Text] [Related]
10. [Statistical parametric mapping analysis of
Chu JS; Liu TH; Zang YZ; Wang KL; Ma HZ; Han CL; Zhao XB; Liu YP; Xia XT; Meng FG
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(33):2632-2635. PubMed ID: 30220149
[No Abstract] [Full Text] [Related]
11. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment.
Gasca-Salas C; Clavero P; García-García D; Obeso JA; Rodríguez-Oroz MC
Hum Brain Mapp; 2016 Mar; 37(3):968-77. PubMed ID: 26663702
[TBL] [Abstract][Full Text] [Related]
12. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study.
Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE
J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793
[TBL] [Abstract][Full Text] [Related]
13. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
Huang C; Mattis P; Perrine K; Brown N; Dhawan V; Eidelberg D
Neurology; 2008 Apr; 70(16 Pt 2):1470-7. PubMed ID: 18367705
[TBL] [Abstract][Full Text] [Related]
14. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment.
Albin RL; Koeppe RA; Burke JF; Giordani B; Kilbourn MR; Gilman S; Frey KA
Arch Neurol; 2010 Apr; 67(4):440-6. PubMed ID: 20385910
[TBL] [Abstract][Full Text] [Related]
15. Correlation between cognitive deficits and glucose hypometabolism in mild cognitive impairment.
Nishi H; Sawamoto N; Namiki C; Yoshida H; Dinh HD; Ishizu K; Hashikawa K; Fukuyama H
J Neuroimaging; 2010 Jan; 20(1):29-36. PubMed ID: 19018949
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease.
Winer JR; Maass A; Pressman P; Stiver J; Schonhaut DR; Baker SL; Kramer J; Rabinovici GD; Jagust WJ
JAMA Neurol; 2018 Feb; 75(2):227-235. PubMed ID: 29228071
[TBL] [Abstract][Full Text] [Related]
17. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
[TBL] [Abstract][Full Text] [Related]
19. Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment.
Song IU; Choi EK; Oh JK; Chung YA; Chung SW
Acta Radiol; 2016 Jan; 57(1):90-7. PubMed ID: 25538106
[TBL] [Abstract][Full Text] [Related]
20. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
